The publisher analyzes the Pharmaceutical Industry in United States in the Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.
Table of Contents
A. Executive Summary
B. Introduction to the Industry
B.1 Industry Definition
B.2 Industry Profile
B.3 OTC Pharmaceuticals in the US
B.4 Generics Market in the US
B.5 Industry Value
B.6 Market Share Analysis
B.7 Market Trends
B.8 Industry Challenges
B.9 Industry Outlook
C. Porter’s Five Forces Strategy Analysis
C.1 Bargaining Power of Buyers
C.2 Bargaining Power of Suppliers
C.3 Competitive Rivalry in the Industry
C.4 Threat of New Entrants
C.5 Threat of Substitutes
D. Conclusion
E. Glossary of Terms
List of Figures
Figure 1: Growth of the US Pharmaceutical Industry by Value (in USD Billion), 2013-2017
Figure 2: Growth of the US OTC Pharmaceutical Industry by Value (in USD Million), 2013-2017
Figure 3: Growth of the US Generic Drugs Market by Value (in USD Billion), 2013-2017
Figure 4: Market Share Analysis of the US Pharmaceutical Industry (%), 2017
Figure 5: Forecast of the US Pharmaceutical Industry (in USD Billion), 2017-2022
Figure 6: Forecast of the US OTC Pharmaceutical Industry (in USD Million), 2017-2022
Figure 7: Forecast of the US Generic Drugs Industry (in USD Billion), 2017-2022
Figure 8: Porter's Five Forces Analysis of the US Pharmaceutical Industry
Figure 9: Bargaining Power of Buyers in the US Pharmaceutical Industry
Figure 10: Bargaining Power of Suppliers in the US Pharmaceutical Industry
Figure 11: Competitive Rivalry in the US Pharmaceutical Industry
Figure 12: Threat of New Entrants to the US Pharmaceutical Industry
Figure 13: Threat of Substitutes to the US Pharmaceutical Industry
List of Tables
Table 1: Growth of the US Pharmaceutical Industry by Value (in USD Billion), 2013-2017
Table 2: Growth of the US OTC Pharmaceutical Industry by Value (in USD Million), 2013-2017
Table 3: Growth of the US Generic Drugs Market by Value (in USD Billion), 2013-2017
Table 4: Forecast of the US Pharmaceutical Industry (in USD Billion), 2017-2022
Table 5: Forecast of the US OTC Pharmaceutical Industry (in USD Million), 2017-2022
Table 6: Forecast of the US Generic Drugs Industry (in USD Billion), 2017-2022
